Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Kangning to Raise $30 Million in China Psychiatric Hospital IPO

publication date: Dec 28, 2017

Wenzhou Kangning Hospital plans a $30 million China IPO to expand its private psychiatric hospital offerings. The company owns three hospitals, all in Zhejiang province, and provides psychiatric services in other hospitals. Two years ago, Kangning, which has a $406 million market capitalization, staged an $88 million IPO on the Hong Kong exchange. More details....

Stock Symbol: (HK: 2120)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.